Mon panier

Mouse TL1A/TNFSF15 ELISA Kit

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
CEA-M259-96tests
$565.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Product Overview

    Mouse TL1A/TNFSF15 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant mouse TL1A/TNFSF15 that is present in biological samples, such as mouse serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:

    1. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    2. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    3. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

  • Product Specifications

    Assay Type
    Sandwich-ELISA
    Analyte
    TL1A
    Format
    96-wells plate breakable into 12 x 8 wells strips
    Reactivity
    Mouse
    Sensitivity
    5 pg/mL
    Assay Time
    2 hr 45 min
    Sample volume
    50 μL
    Range
    9.375 pg/mL-600 pg/mL
    Sample Type
    For the quantitative determination of mouse TL1A in serum, plasma and cell supernatant.

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Application

    The kit is developed for quantitative detection of natural and recombinant mouse TL1A in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow

    TL1A Workflow

  • Storage

    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    CEA259-C01
    Pre-coated Anti-TL1A Antibody Microplate
    1 plate
    CEA259-C02
    Mouse TL1A Standard
    12 μg×2
    CEA259-C03
    Biotin-Anti-TL1A Antibody Con. Solution
    100 μL
    CEA259-C04
    Biotin-Antibody Dilution Buffer
    8 mL
    CEA259-C05
    Streptavidin-HRP Con. Solution
    500 μL
    CEA259-C06
    Streptavidin-HRP Dilution Buffer
    15 mL
    CEA259-C07
    20×Washing Buffer
    50 mL
    CEA259-C08
    Sample Dilution Buffer
    15 mL×2
    CEA259-C09
    Substrate Solution
    12 mL
    CEA259-C10
    Stop Solution
    6 mL
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data 

    Please refer to DS document for the assay protocol.

     TL1A TYPICAL DATA

    For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of TL1A is less than 5 pg/mL.

Validation
  • Intra-Assay Statistics

    Ten replicates of each of three samples containing different mouse TL1A concentrations were tested in one assay. Acceptable criteria: CV<10%.

     TL1A INTRA-ASSAY STATISTICS
  • Inter-Assay Statistics

    Three samples containing different concentrations of mouse TL1A were tested in independent assays. Acceptable criteria: CV<15%.

     TL1A INTER-ASSAY STATISTICS
  • Recovery

    Recombinant TL1A was spiked into three mouse serum samples, and then analyzed. The average recovery of TL1A for serum samples is 107.67%.

     TL1A RECOVERY

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Tumor necrosis factor superfamily member 15

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    18 Détails

  • Étape de développement la plus élevée:

    Phase 3 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs